Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Education & Training

  • PHD, 2009
    John Hopkins University Bloomberg School Of Public Health
  • Fellowship, Pediatric Hematology-Oncology, 2008
    Johns Hopkins Hospital
  • Residency, Pediatrics, 2004
    New York University
  • Internship, Pediatrics, 2002
    New York Hospital
  • MD, 2001
    University of Illinois College of Medicine
  • BA, 1996
    Northwestern University

Board Certifications

  • American Board of Pediatrics
  • American Board of Pediatrics/Hematology-Oncology

National Provider ID: 1558415224


AeRang Kim, M.D., Ph.D., is a member of the solid tumor faculty at Children’s National Hospital and an Associate Professor of Pediatrics. Dr. Kim's specializes in sarcomas and developmental therapeutics. Her research focuses on development of novel therapeutics for pediatric cancer including pre-clinical testing of novel agents, pharmacokinetic analysis, developing innovative methods for toxicity monitoring and clinical trial design. She serves as the principal investigator of multiple early phase trials in pediatric oncology, sarcomas and NF1 associated tumors.

Research & Publications

Characteristics and outcome of pediatric patients enrolled on phase I oncology trials

(2008) The Oncologist

Characteristics of children enrolled on treatment trials for NF1 related plexiform neurofibromas

(2009) Neurology

Sorafenib and Sunitinib

(2009) The Oncologist

The prognostic value of tumor markers in newly diagnosed patients with primary central nervous system germ cell tumors

(2008) Pediatric Blood Cancer